Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Siddiqui Sami A.Chief Financial Officer | Grant or award | A | — 695 sh | Jan 8, 2026 |
| 9 | Siddiqui Sami A.Chief Financial Officer | Grant or award | A | — 23 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $61K 5,000 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Rayphole Robert P.VP CAO & Controller | Grant or award | A | — 16.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Schaub SydneySVP and Chief Legal Officer | Grant or award | A | — 63.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Williams Ashbel CDirector | Grant or award | A | — 26 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Issa Mohamed KhairieEVP, Head of US Oncology | Tax withholding · 10b5-1 plan | F | $881K 8,264 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Kodama Wade KCFO | Tax withholding | F | — 695 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 9 | Giroux RichardCFO & COO | Option exercise | M | — 52.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 67 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 23 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Ware J. AnthonyDirector | Grant or award | A | — 4,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 451 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lehner Keefer McGovernSee Remarks | Disposition to issuer | D | — 10.1K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Boone KarenDirector | Option exercise | M | — 280 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 7,500 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Option exercise | M | — 6,145 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lehner Keefer McGovernSee Remarks | Disposition to issuer | D | — 94.3K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Galligan Mary EDirector | Grant or award | A | — 62 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 9 | Rodgers Ben CEVP and CFO | Grant or award | A | — 44.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 21.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Malzahn CraigChief Technology Officer | Grant or award | A | — 35.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Curtis Thomas BenjaminPres., BK US & CA | Grant or award | A | — 24 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Foote TimChief Financial Officer | Option exercise | M | — 4,616 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $167K 957 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Crowell KimberlyDirector | Grant or award | A | — 27 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $566K 3,251 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 9 | Maddox Mark DExecutive VP - Administration | Grant or award | A | — 44.9K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 9 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $289K 1,660 sh | Jan 8, 2026 traded Jan 8, 2026 |
| 9 | Lizzul Paul F.Chief Medical Officer | Grant or award | A | — 29.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 8 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $7,750 100 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 8 | Moll Laurent RChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $23K 1,420 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 8 | Lee JanetGC & Corporate Secretary | Open-market sale · 10b5-1 plan | SELL | $128K 250 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 7 | Cooper Matthew WGeneral Counsel & Corp Secy | Open-market sale · 10b5-1 plan | SELL | $500K 2,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 7 | Scaringe Robert JDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $339K 17.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $221K 19.2K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Santelmo Thiago TPresident, International | Grant or award | A | — 180 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Perdue PeterPresident, Popeyes-US & Canada | Grant or award | A | — 21 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Santelmo Thiago TPresident, International | Grant or award | A | — 17 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Foote TimChief Financial Officer | Option exercise | M | — 2,367 sh | Jan 8, 2026 traded Jan 6, 2026 |